Life sciences companies a likely targets of these kinds of attacks.
Abhay Kini
Advertisement
Articles by Abhay Kini
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
2
FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults
3
Pharmaceutical Executive Daily: FDA Approves Zanvastro
4
Your Questions Answered: The Biggest Pharma and Biotech Stories This Week
5